Vito Longo

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Extracellular Matrix

Prognostic Factors

Top Venues

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Vito Longo, Alessandro Rizzo, Annamaria Catino, Michele Montrone, Domenico Galetta
Safety evaluation of immune checkpoint inhibitors combined with chemotherapy for the treatment of small cell lung cancer: A meta-analysis of randomized controlled trials. Thoracic cancer (2023)
Vito Longo, Alessandro Rizzo, Annamaria Catino, Michele Montrone, Domenico Galetta
Safety evaluation of immune checkpoint inhibitors combined with chemotherapy for the treatment of small cell lung cancer: A meta-analysis of randomized controlled trials. Thoracic cancer (2023)
Vito Longo, Annamaria Catino, MIchele Montrone, Domenico Galetta, Domenico Ribatti
Controversial role of mast cells in NSCLC tumor progression and angiogenesis. Thoracic cancer 13 (21) (2022)
Vito Longo, Pamela Pizzutilo, Annamaria Catino, Michele Montrone, Francesco Pesola, Ilaria Marerch, Domenico Galetta
Prognostic factors for survival in extensive-stage small cell lung cancer: An Italian real-world retrospective analysis of 244 patients treated over the last decade. Thoracic cancer (2022)
Vito Longo, Annamaria Catino, Michele Montrone, Pamela Pizzutilo, Francesco Pesola, Ilaria Marech, Iolanda Capone, Arsela Prelaj, Domenico Galetta
Successful treatment of triple EGFR mutation T785A/L861Q/H297_E298 with afatinib. Thoracic cancer 12 (13) (2021)